U.S., June 17 -- ClinicalTrials.gov registry received information related to the study (NCT07651930) titled 'Full-Spectrum Cannabidiol Oil for Anxiety and Depressive Symptoms in Parkinson's Disease' on July 07, 2025.
Brief Summary: Parkinson's disease (PD) is a progressive neurodegenerative disorder primarily characterized by motor symptoms such as bradykinesia, rigidity, and tremor. However, non-motor symptoms, particularly anxiety and depression, are also common and substantially affect patients' daily functioning and quality of life. Cannabidiol (CBD), a non-intoxicating constituent of Cannabis sativa, has demonstrated anti-inflammatory, antioxidant, and anxiolytic properties and has shown therapeutic potential in several clinical setti...